NEW YORK, July 20, 2016 /PRNewswire/ --
The Scientific and Technical Instruments industry is a very
competitive landscape given the demand for related apparatus.
Companies in this space are always competing to produce
high-quality products while controlling manufacturing costs. In
today's pre-market research, Stock-Callers.com shifts focus onto
Trimble Navigation Ltd (NASDAQ: TRMB), Garmin Ltd (NASDAQ: GRMN),
Keysight Technologies Inc. (NYSE: KEYS), and Cepheid (NASDAQ:
CPHD). Learn more about these stocks by accessing their free notes
at:
http://stock-callers.com/registration
Trimble Navigation
On Tuesday, Sunnyvale,
California headquartered Trimble Navigation Ltd's stock
dropped 0.47% to close the day at $25.43 with a total volume of 960,591 shares
traded. The Company's shares have advanced 0.63% in the previous
three months and 18.55% on an YTD basis. The stock is trading 1.84%
above its 50-day moving average and 11.78% above its 200-day moving
average. Additionally, shares of Trimble Navigation, which provides
technology solutions to enhance the work processes of professionals
and field mobile workers worldwide, have a Relative Strength Index
(RSI) of 56.86.
On June 28th, 2016,
research firm JP Morgan downgraded the Company's stock rating from
'Overweight' to 'Neutral'.
On July 18th, 2016,
Trimble Navigation and CSCEC No. 1 Building Group Corporation
Limited, one of the largest building contractors in China, announced plans to collaborate to
explore the applications of mixed-reality technology in the
Architecture, Engineering and Construction industry. As part of
Trimble's Mixed-Reality Pilot Program, CSCEC Group 1 is the first
organization in China to use
Microsoft HoloLens and Trimble Mixed-Reality solutions. TRMB
complete notes are just a click away at:
http://stock-callers.com/registration/?symbol=TRMB
Garmin
Shares in Schaffhausen, Switzerland-based Garmin Ltd rose 0.51%,
finishing the session at $45.66. The
stock recorded a trading volume of 702,922 shares. The Company's
shares have gained 8.51% in the last month, 8.49% in the previous
three months, and 25.96% since the start of this year. The stock is
trading above its 50-day and 200-day moving averages by 9.39% and
20.53%, respectively. Furthermore, shares of Garmin, which together
with its subsidiaries, designs, develops, manufactures, markets,
and distributes a range of navigation, communication, and
information devices worldwide, have an RSI of 71.47.
On July 07th, 2016,
Garmin International Inc., a unit of Garmin Ltd., announced the
gWind™ Wireless 2 Transducer, a new easy-to-install wind solution
for masts up to 50 feet that wirelessly sends essential wind data
to GNX™ Wind instruments or a compatible Garmin GPSMAP®
chartplotter, eliminating the need to run wires through the mast.
The gWind Wireless 2 is the first and only wireless wind transducer
on the market that connects directly to a compatible chartplotter.
The complimentary notes on GRMN can be accessed at:
http://stock-callers.com/registration/?symbol=GRMN
Keysight Technologies
Santa Rosa, California
headquartered Keysight Technologies Inc.'s stock finished 0.20%
lower at $29.26 at the close, with a
total volume of 546,892 shares traded. The Company's shares have
advanced 7.34% in the previous three months and 3.28% on an YTD
basis. The stock is trading above its 50-day and 200-day moving
averages by 0.51% and 4.05%, respectively. Additionally, shares of
Keysight Technologies, which provides electronic design and test
solutions to communications and electronics industries in
the United States and
internationally, have an RSI of 55.51.
On July 11th, 2016,
Keysight Technologies introduced its Signal Optimizer software -the
industry's first and only all-in-one software for calibration,
signal creation and signal analysis of 5G candidate waveforms.
Register for free on Stock-Callers.com and activate the trade alert
on KEYS at:
http://stock-callers.com/registration/?symbol=KEYS
Cepheid
Shares in Sunnyvale, California
headquartered molecular diagnostics company, Cepheid, ended
Tuesday's session 0.70% lower at $32.44 with a total volume of 561,247 shares
traded. The stock has advanced 11.75% in the last month. The
Company's shares are trading 11.47% above their 50-day moving
average and 0.05% above their 200-day moving average. Moreover,
shares of Cepheid, which develops, manufactures, and markets
integrated systems for testing in the clinical and non-clinical
markets, have an RSI of 58.72.
On June 30th, 2016,
Cepheid announced that it has received clearance from the U.S. Food
and Drug Administration (FDA) for expanded claims for Xpert®
Carba-R, the first FDA-cleared test for detection of carbapenem
resistance genes of multidrug resistant 'superbugs'.
Following initial clearance in March for detection and
differentiation of carbapenemase genes in pure bacterial isolates,
the latest clearance extends use of the assay to the analysis of
direct rectal swab specimens, and positions Xpert Carba-R as a
valuable tool for the identification of colonized patients and as
an aid to infection control efforts. Get free access to your notes
on CPHD at:
http://stock-callers.com/registration/?symbol=CPHD
--
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored
reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and
micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
SC has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and
reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by SC. SC is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither SC nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company we are
covering and wish to no longer feature on our coverage list contact
us via email and/or phone between 09:30 EDT
to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street,
Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA